WADA approved 2011 Prohibited List

The World Anti-Doping Agency (WADA) has approved the 2011 Prohibited List. The list will come into effect from 1 January 2011 onwards.

Major changes of the list include:

Non-Approved Substances

A new Section “S0. Non-Approved Substances” has been added: All pharmacological substances which is not addressed by any of the subsequent sections of the List and with no current approval by any governmental regulatory health authority for human therapeutic use (i.e. drugs under pre-clinical or clinical development or discontinued) is prohibited at all times.

Declaration of Use is no longer applicable

The concept of Declaration of Use is totally removed. Beta-2 agonists – The use of salbutamol and salmeterol by inhalation in accordance with the manufacturers’ recommended therapeutic regime is permitted and no longer requires Declaration of Use. Glucocorticosteroids – The use of glucocorticosteroids by oral, intravenous, intramuscular or rectal are still prohibited. However, administration by other routes (e.g. intraarticular, periarticular, peritendinous, epidural, intradermal, and inhalation) no longer requires Declaration of Use.

Platelet-derived preparations

Intra-muscular use of Platelet-Derived Preparations (PRP) has been removed from the Prohibited List.

Please note the 2010 Prohibited List will remain effective until 1 January 2011.